Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.4B
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
66.2K
-
Shares change
-
+58.5K
-
Total reported value, excl. options
-
$302K
-
Value change
-
+$268K
-
Put/Call ratio
-
0.28
-
Number of buys
-
10
-
Number of sells
-
-6
-
Price
-
$4.57
Significant Holders of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) as of Q2 2025
22 filings reported holding BLRX - BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share as of Q2 2025.
BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.2K shares
of 2.4B outstanding shares and own 0% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (15K shares), SIMPLEX TRADING, LLC (14.1K shares), TWO SIGMA SECURITIES, LLC (13.8K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.1K shares), RHUMBLINE ADVISERS (4.28K shares), CITIGROUP INC (4.01K shares), WELLS FARGO & COMPANY/MN (1.75K shares), MORGAN STANLEY (1.54K shares), Nemes Rush Group LLC (250 shares), and NATIONAL BANK OF CANADA /FI/ (200 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.